Skip to main content
Year archive

CJ Bioscience — 2023 filings

All 53 regulatory filings released by CJ Bioscience (311690) in 2023, sourced directly from the official regulator.

53 Filings
2023 Period
2023 filings (53)
Filing Released Lang
합병등종료보고서(자산양수도)
M&A Activity
2023-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-11 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2023-12-11 Korean
주요사항보고서(유형자산양도결정)
Regulatory Filings
2023-12-11 Korean
특수관계인에대한부동산매도
Transaction in Own Shares
2023-12-11 Korean
가족친화인증ㆍ유효기간연장ㆍ인증취소(자율공시)(가족친화 인증)
Environmental & Social Information
2023-12-01 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2023-11-29 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-09-06 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-09-04 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2023-08-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-08-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-08-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2023-08-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-08-22 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2023-08-18 Korean
증권발행실적보고서
Share Issue/Capital Change
2023-08-18 Korean
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Regulatory Filings
2023-08-14 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change
2023-08-11 Korean
유상증자최종발행가액확정
Capital/Financing Update
2023-08-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-08-07 Korean
특수관계인의유상증자참여
Share Issue/Capital Change
2023-08-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-08-07 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-08-07 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change
2023-08-07 Korean
[기재정정]투자설명서
Capital/Financing Update
2023-08-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-07-25 Korean
유상증자1차발행가액결정
Share Issue/Capital Change
2023-07-06 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-07-06 Korean
권리락(유상증자)
Share Issue/Capital Change
2023-07-06 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change
2023-07-06 Korean
[기재정정]투자설명서
Capital/Financing Update
2023-07-06 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-06-26 Korean
투자설명서
Capital/Financing Update
2023-06-22 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(마이크로바이옴 면역항암치료제 CJRB-101의 한국 식품의약품안전처(MFDS) 제1/2상 임상시험계획(IND) 승인)
Legal Proceedings Report
2023-06-15 Korean
[기재정정]증권신고서(지분증권) (2023.08)
Share Issue/Capital Change
2023-06-07 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification
2023-05-31 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update
2023-05-22 Korean
증권신고서(지분증권) (2023.08)
Share Issue/Capital Change
2023-05-22 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
투자판단관련주요경영사항(마이크로바이옴 면역항암치료제 CJRB-101의 한국 식품의약품안전처(MFDS) 제1/2상 임상시험계획(IND) 신청)
Legal Proceedings Report
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-28 Korean
투자판단관련주요경영사항(마이크로바이옴 치료제 연구개발을 위한 기술도입 계약 체결)
Regulatory Filings
2023-03-27 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-20 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-10 Korean
주주총회소집결의
AGM Information
2023-02-28 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2023-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-01 Korean
투자판단관련주요경영사항(마이크로바이옴 면역항암치료제 CJRB-101의 미국 FDA 제1/2상 임상시험계획(IND) 승인)
Legal Proceedings Report
2023-01-20 Korean